Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071038 | PMC |
| http://dx.doi.org/10.1038/bjc.1963.54 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Pathology and molecular pathology of carcinoma of the penis].
Pathologie (Heidelb)
December 2024
Institut für Pathologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Krankenhausstraße 8-10, 91054, Erlangen, Deutschland.
Penile carcinoma exhibits significant geographic variation in incidence, ranking 30th globally among newly diagnosed cancers with an annual rate of 0.84 cases per 100,000 men. Particularly high incidence rates of up to 2.
View Article and Find Full Text PDFPhotodynamic therapy with hematoporphyrin derivative for the treatment of penile verrucous carcinoma: A case report.
Photodiagnosis Photodyn Ther
December 2024
The Fifth People's Hospital of Hainan Province,Haikou City, Hainan Province, China. Electronic address:
Verrucous carcinoma, a well-differentiated variant of squamous cell carcinoma with low-grade malignancy, is often associated with localized human papillomavirus (HPV) infection and excessive penile foreskin. We report a 45-year-old male who presented with a verrucous plaque on the glans penis for over four months, along with itching. Examination revealed a verrucous, erosive lesion with a cauliflower-like surface, firm texture, and irregular shape, accompanied by pain, bleeding, and a foul odor.
View Article and Find Full Text PDFA Rare Case of Malignant Melanoma of the Glans Penis in a Young Male Treated with an Organ-Preserving Surgical Procedure.
Cureus
October 2024
Urology, SRM Medical College Hospital and Research Centre, Chennai, IND.
Penile melanoma is a rare and highly invasive cancer that is generally diagnosed in the sixth to seventh decades of life. We report a rare case of primary malignant melanoma of the glans penis in a 38-year-old man who presented with a proliferative lesion over the glans with discoloration for six months. The clinical and metastatic workups were unremarkable.
View Article and Find Full Text PDFCOVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center.
Urol Int
October 2024
Department of Urology, University Medical Center Rostock, Rostock, Germany.
Introduction: To assess differences in referral and pathologic outcomes for uro-oncology cases prior to, during, and after the COVID-19 pandemic, comparing clinical and pathological data from cancer surgeries performed at a university medical center between 2018 and 2023.
Methods: We collected data of 212 patients with radical prostatectomy (RP) for prostate cancer, 157 patients with radical cystectomies (RCs) for bladder cancer, 36 patients with radical nephroureterectomies (RNUs) for upper tract urothelial carcinoma, 133 patients with partial nephrectomies (PNs), and 160 patients with radical nephrectomies (RNs) for renal cancer, 93 patients with orchifunicolectomy for testicular cancer, 39 patients with newly diagnosed penile cancer. Data from patients treated between 2018 and February 2020 (before the COVID-19 pandemic) were compared with data from patients treated between March 2020 and March 2022 (during the COVID-19 pandemic) and between April 2022 and February 2023 (after the COVID-19 pandemic).
A comprehensive review of current knowledge on penile squamous cell carcinoma.
Front Oncol
May 2024
Department of Anatomical Sciences, School of Medicine, St George's University, True Blue, Grenada.
Neoplasm of the penis is relatively rare in most regions representing 0-2% of cancers worldwide. While the penis can be affected by sarcomas, basal cell carcinomas or even melanoma, Penile Squamous Cell Carcinoma (PSCC) represents approximately 95% of all penile neoplasms. Despite its rarity and most common presentation at later decades of life most individuals diagnosed with PSCC are faced with significant decrease in quality of life.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!